The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
My day-to-day is pretty much operational and involves a little bit of everything. When I first started with SOHO 15 years ago, we all wore so many different hats; nobody did just one thing.
Amifostine and uproleselan also showed “meaningful promise” for reducing mucositis and delaying severe diarrhea and improving GI quality of life, respectively, but require prospective validation, wrote the study’s authors, led by Vraj Rangrej, MD, of Mayo Clinic in Jacksonville, Florida.
Dr. O’Brien, a founding member of the society, has contributed far beyond her scientific expertise. Known for her dedication and commitment to the field, she has supported SOHO’s growth and mission since the society’s earliest days.
Oral abstract ALL-584 takes top honors in SOHO 2026 abstract awards.
The study, led by Ashutosh Wechalekar, MD, of National Amyloidosis Centre and University College London Hospitals in the United Kingdom, analyzed a combined population of patients with stage 3a or 3b AL amyloidosis from two phase 3 randomized trials in the Cardiac Amyloid Reaching for Extended Survival (CARES) program.
In the past decade, the introduction of highly effective immune and cell therapies has dramatically changed our ability to treat children with ALL.
SOHO Insider is the official media platform of the Society of Hematologic Oncology. The SOHO Insider Editorial Board is comprised of leading hematologists. Learn more about our editorial board and SOHO Insider platforms.
To access the SOHO Career Center click the following link.
